Tung Wai Auyeung

Tung Wai Auyeung

Auto-generated profile, based on publicly available information

Tung Wai Auyeung

Jockey Club Institute of Aging, The Chinese University of Hong Kong, Hong Kong

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2025 in The Journal of Frailty & Aging
Verified
Journal Article
Open access
TATung Wai Auyeung
Tung Wai Auyeung
CKCarolyn Poey Lyn Kng
Carolyn Poey Lyn Kng
TCTak Yeung Chan
Tak Yeung Chan
EHElsie Hui
Elsie Hui
CLChi Shing Leung
Chi Shing Leung
TYTeresa Kim Kum Yu
Teresa Kim Kum Yu
Electronic health record (EHR) has been in place in many parts of the world. This fits in very well to the frailty index calculation proposed by Rockwood and thus a frailty index can potentially be generated automatically from an EHR database. Therefore, the Hong Kong Hospital Authority (HA) attempted to develop an electronic frailty index (HK eFI), by employing thirty-eight health variables from her own EHR database. Five cohorts of patients aged 60 years or above ever attended any services provided by the Hong Kong HA in the year 2015, 2016, 2017, 2018 and 2019, were included. The HK eFI trajectory with ageing, generated by the five cohorts, were compared to the one described by Rockwood's group. Following the UK eFI method, 4 levels of frailty were categorized, and they were examined whether they were related to mortality, readmission rate and hospitalization patient days. Each successive cohort consisted of increasing number of patients aged 60 years or above. (2015, 1.14 million; 2016, 1.19 million; 2017,1.25 million; 2018, 1.31 million; 2019, 1.38 million). The gradients of the five trajectories ranged from 0.035 to 0.037, representing an increase in FI approximately 3.6 % annually. The intercept of the curves converged at 0.1, representing the FI at age 60 years was 0.1. Compared to the fit group, the adjusted hazard ratios of mortality of the mild, moderate and severe frail group were 1.77, 3.31 and 6.65 respectively and they were all statistically higher than the fit group. (p < 0.005) Likewise, there was a stepwise increase in readmission rate and hospital patient days utilization with increasing frailty levels. It is feasible to develop an eFI and a biological age trajectory from a large EHR database with local adaptation.

14 May 2026 in Heart, Lung and Circulation
Verified
Journal Article
Open access
TATung Wai Auyeung
Tung Wai Auyeung
JLJenny Shun Wah Lee
Jenny Shun Wah Lee
Erik FungErik Fung
Erik Fung
JLJason Leung
Jason Leung
TKTimothy Kwok
Timothy Kwok
Jean WooJean Woo
Jean Woo
This community-based cohort study aimed to examine whether baseline heart diseases predict incident frailty over 20 years. A total of 3,998 non-frail adults (2,000 men, 1,998 women) aged ≥65 years were included at study entry. Heart disease was defined as self-reported, medication-verified chronic heart failure, myocardial infarction, or angina pectoris. Frailty was assessed at interval using the FRAIL scale (score ≥3 defining frailty) at baseline and was repeated at: 2-years, 4-years, 14-years, 18-years and finally 20-years follow-up. Cox proportional hazards models, stratified by sex and adjusted for age, diabetes, hypertension, smoking, and BMI, analysed the association between heart disease and time to incident frailty. At baseline, heart disease prevalence was 18.3% in men and 16.5% in women. Over a total follow-up duration of 62,012 person-years, baseline heart disease was demonstrated to be a significant independent predictor of frailty after adjustment for confounders. The risk was greater in men (adjusted hazard ratio [aHR] 1.77, 95% confidence interval [CI]: 1.26-2.48, p 0.001) than in women (aHR 1.34, 95% CI: 1.00 - 1.80; p=0.048) CONCLUSIONS: Heart diseases, apart from being a primary driver of mortality, are significant independent predictors of incident frailty in older adults, with a stronger effect observed in men. This highlights the need for frailty screening and preventive strategies in older patients with heart disease.

3 November 2026 in European Heart Journal Open
Verified
Journal Article
Open access
KNKwan Hung Ng
Kwan Hung Ng
GLGloria H W Lau
Gloria H W Lau
PCPik Sui Briony Chan
Pik Sui Briony Chan
KYKa Man Yu
Ka Man Yu
JLJenny S W Lee
Jenny S W Lee
Erik FungErik Fung
Erik Fung
Aims: Available atherosclerotic cardiovascular disease (ASCVD) risk calculators predict acute events suboptimally in the elderly. We aimed to determine if DNA methylation (epigenetic) age acceleration (EAA) was associated with atherogenic inflammageing and predictive of adverse outcomes incremental to SCORE2-OP and PREVENT. Methods and results: Participants stratified using the FRAIL scale (robust/pre-frail/frail) were randomly selected in approximately equal proportions from a parent cohort of 1400 community-living older adults. Five epigenetic clocks were developed from MethylationEPIC-analysed blood DNA to calculate baseline EAA by regressing chronological age on epigenetic age. Proton-nuclear magnetic resonance was used to profile serum lipoproteins/lipids and glycosylated acetyls. The primary outcome was a composite endpoint of incident all-cause mortality, cardiovascular hospitalization (CVH), and ASCVD/acute coronary syndrome hospitalization (AAH). Time-to-event analyses were performed. Among epigenetic clocks analysed in 535 individuals aged 60–99 years, GrimAge2 EAA (Grim2AA) was most significantly associated with cardiometabolic comorbidities and atherogenic inflammageing. During follow-up of 4.6 years, 30 were lost to follow-up, whereas 42 experienced AAH. Cox regression determined that Grim2AA was predictive of CVH (P < 0.05) and AAH (P < 0.01) but not all-cause mortality. For every 1-year increase in Grim2AA, the hazards of CVH and AAH were significantly increased by 6% and 11%, respectively. The predictive performance of AAH by SCORE2-OP and PREVENT was improved by Grim2AA: concordance index 0.693–0.734 (P < 0.05) and 0.682–0.725 (P < 0.01), respectively. In Kaplan–Meier analysis, the probability of AAH was significantly higher in individuals with Grim2AA ≥ 0 (acceleration or none) than <0 (deceleration) (P < 0.01). Conclusion: Grim2AA may independently predict AAH incremental to SCORE2-OP and PREVENT in older adults.